How can 3D printed orphan drugs improve life of patients? – The point of view of Antonio Benedetti, CEO of Cycle Pharmaceuticals

1 Response

  1. March 9, 2018

    […] an interview, speaking about Aprecia’s 3D printing technology, Cycle Pharmaceuticals’ CEO, Antonio Benedetti, explained that, to 3D print drugs, this […]

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: